Suscribirse

AINAR Trial: A randomized controlled trial to assess the usefulness of Artificial Intelligence based game to conquer needle fear in blood donors - 07/09/26

Doi : 10.1016/j.tracli.2026.09.001 
Radheshyam Meher, MD 1, 2, 3, 4 , Gopal K Patidar, MD 1, 5, ⁎
1 All India Institute of Medical Sciences, New Delhi, India 
2 All India Institute of Medical Sciences, Raipur, India 
3 Senior Resident, Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India 
4 Assistant Professor, Department of Transfusion Medicine, All India Institute of Medical Sciences, Raipur, India 
5 Additional Professor, Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India 

⁎ Corresponding author: Additional Professor, Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India Additional Professor, Department of Transfusion Medicine, All India Institute of Medical Sciences New Delhi India
En prensa. Manuscrito Aceptado. Disponible en línea desde el Monday 07 September 2026
This article has been published in an issue click here to access

Highlights

•
AINAR is an artificial intelligence-based game intervention designed to reduce needle fear in blood donors.
•
AINAR was associated with greater reduction in donor-reported needle fear.
•
Immediate VVR incidence was lower with AINAR, but the difference was not statistically significant.
•
Findings among donors with previous VVR or elevated pre-donation fear were exploratory and require confirmation in larger studies.

El texto completo de este artículo está disponible en PDF.

Abstract

Background: Needle fear and anxiety are important contributors to vasovagal reactions (VVR) and poor retention among blood donors. This study evaluated the usefulness of Artificial Intelligence for Needle Anxiety Reduction (AINAR), an artificial intelligence-based game intervention, in reducing needle fear and VVR during blood donation.

Methodology: Single-centre, parallel-group randomized controlled trial conducted at AIIMS, New Delhi (2025). Total of 3000 eligible whole blood donors were randomized equally into control and AINAR groups. Donors in the intervention arm played the AINAR game during needle insertion and removal. The primary outcome was immediate VVR incidence. Secondary outcomes included needle fear, anxiety scores, and AINAR colour feedback responses. Fear and anxiety were assessed using a 5-point Likert scale before and after donation.

Results: The overall incidence of VVR was 1.47%. VVR occurred in 1.8% of donors in the control group and 1.13% in the AINAR group, corresponding to a relative risk of 0.63, representing a reduction that did not reach statistically significance. Needle fear significantly decreased after donation in both groups, with a greater reduction in the AINAR group. Moderate-to-severe pre-donation needle fear was strongly associated with VVR (5.6% vs 1.3%, p<0.001). Persistent post-donation fear was strongly associated with VVR (aOR 9.19, 95%CI 3.19–26.48), while prior VVR also remained independently associated with VVR (aOR 4.65, 95%CI 1.15–18.82). Exploratory subgroup analyses suggested lower VVR incidence with AINAR among some higher-risk donor groups. AINAR colour changes correlated with donor-reported fear and anxiety.

Conclusion: AINAR was associated with a greater reduction in donor-reported needle fear, whereas the reduction in immediate VVR did not reach statistical significance. Exploratory findings among high-risk donors warrant further investigation. Larger multicentre studies are required to determine whether AI-assisted behavioural interventions can reduce VVR and improve donation experience.

El texto completo de este artículo está disponible en PDF.

Key words : Blood donation, Vasovagal reaction, needle fear, artificial intelligence, hemovigilance



© 2026  Société francophone de transfusion sanguine (SFTS). Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.